Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …

The amyloidoses are a group of protein-folding disorders in which≥ 1 organ is infiltrated by
proteinaceous deposits known as amyloid. The deposits are derived from 1 of several …

Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with
a median survival from diagnosis, if untreated, ranging from< 6 months for light chain …

The amyloidoses are a group of systemic diseases characterized by organ deposition of
misfolded protein fragments of diverse origins. The natural history of the disease …

In contrast to their role in cell types with higher energy demands, mitochondria in endothelial
cells primarily function in signaling cellular responses to environmental cues. This article …

GLP-1 receptor (GLP-1R) agonists may improve endothelial function (EF) via metabolic
improvement and direct vascular action. The current study determined the effect of GLP-1R …

Systemic amyloid light-chain (AL) amyloidosis is associated with rapidly progressive and
fatal cardiomyopathy resulting from the direct cardiotoxic effects of circulating AL light chain …

AL amyloidosis is the consequence of clonal production of amyloidogenic immunoglobulin
light chain (LC) proteins, often resulting in a rapidly progressive and fatal amyloid …

Aim The aim of this study was to evaluate the diagnostic utility of high‐sensitivity cardiac
troponin T (hs‐cTnT) levels in discriminating cardiac amyloidosis from patients with cardiac …

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy characterized by extracellular
deposition of mis-folded proteins called amyloid. Cardiac complications of CA are several …